System and method for extraction and cryopreservation of bone marrow

Inventors

Woods, Erik John • Johnstone, Brian H. • GU, Dongsheng • Sherry, Aubrey Marie • Musall, Kelsey Gwen • Woods, John R. • Hardin, James • Hooks, Alan

Assignees

Ossium Health Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-10995318-B2

Patent

Publication Date

2021-05-04

Expiration Date


Abstract

Methods are provided for extracting bone marrow cells from bone obtained from deceased donors, for preparing the bone marrow for cryopreservation and for obtaining desired cells from cryopreserved and fresh bone marrow.

Core Innovation

The invention describes the recovery of stem cells from cadaver bone or cadaver bone fragments. The method centers on treating the bone through sequential chemical pretreatment [procedural detail omitted for safety], processing the treated bone to extract bone marrow cells, and collecting those cells. The disclosure further reports the recovery and characterization of CD34+ hematopoietic stem and progenitor cells as well as vertebral bone-adherent mesenchymal stromal/stem cells.

The background technical problem or unmet need is not explicitly described in the supplied patent content beyond the stated aim of optimizing recovery. The disclosure reports experimental results relating donor ischemia and cooling times to cell viability, colony-forming unit outcomes, and expansion potential, alongside descriptions of bone-processing workflows, but does not explicitly detail a specific prior art limitation.

Claims Coverage

The claims identify one independent claim and two inventive features directed to stem-cell recovery from cadaver bone or cadaver bone fragments.

Stem-cell recovery from cadaver bone

The claim covers obtaining cadaver bone or fragments, applying sequential chemical pretreatment [procedural detail omitted for safety], processing the treated bone to extract bone marrow cells, and collecting the extracted cells to recover stem cells.

Recovery of bone-associated cell populations

The supplied description identifies CD34+ hematopoietic stem and progenitor cells and vertebral bone-adherent mesenchymal stromal/stem cells as recovered cell populations, whereas the independent claim does not specify these specific cell types.

The independent claim covers stem-cell recovery from cadaver bone through chemical pretreatment and subsequent marrow-cell extraction and collection, with the description further documenting recovery of specific hematopoietic and bone-adherent stromal/stem-cell populations.

Stated Advantages

The claim states that the method is for optimizing recovery of stem cells from cadaver bone or cadaver bone fragments.

Reported results include viable CD34+ recovery under defined ischemia conditions and substantial expansion potential for vertebral bone-adherent mesenchymal stromal/stem cells.

Documented Applications

Recovery of stem cells from deceased-donor cadaver bone or bone fragments, including marrow-cell collection and recovery of CD34+ hematopoietic stem and progenitor cells.

Recovery of vertebral bone-adherent mesenchymal stromal/stem cells (vBA-MSCs) from cadaver bone.

Cadaveric marrow processing and cryopreservation.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.